vs
Side-by-side financial comparison of JOINT Corp (JYNT) and Laird Superfood, Inc. (LSF). Click either name above to swap in a different company.
JOINT Corp is the larger business by last-quarter revenue ($15.2M vs $13.3M, roughly 1.1× Laird Superfood, Inc.). JOINT Corp runs the higher net margin — 6.5% vs -13.2%, a 19.7% gap on every dollar of revenue. On growth, Laird Superfood, Inc. posted the faster year-over-year revenue change (15.0% vs 3.1%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs -28.6%).
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
JYNT vs LSF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $15.2M | $13.3M |
| Net Profit | $991.1K | $-1.8M |
| Gross Margin | 81.4% | 34.1% |
| Operating Margin | 4.9% | -13.5% |
| Net Margin | 6.5% | -13.2% |
| Revenue YoY | 3.1% | 15.0% |
| Net Profit YoY | 5510.5% | -341.4% |
| EPS (diluted) | $0.06 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.2M | $13.3M | ||
| Q3 25 | $13.4M | $12.9M | ||
| Q2 25 | $13.3M | $12.0M | ||
| Q1 25 | $13.1M | $11.7M | ||
| Q4 24 | $14.7M | $11.6M | ||
| Q3 24 | $30.2M | $11.8M | ||
| Q2 24 | $30.3M | $10.0M | ||
| Q1 24 | $29.7M | $9.9M |
| Q4 25 | $991.1K | $-1.8M | ||
| Q3 25 | $855.0K | $-975.1K | ||
| Q2 25 | $93.4K | $-362.2K | ||
| Q1 25 | $967.8K | $-156.2K | ||
| Q4 24 | $17.7K | $-398.4K | ||
| Q3 24 | $-3.2M | $-166.1K | ||
| Q2 24 | $-3.6M | $-239.1K | ||
| Q1 24 | $947.0K | $-1.0M |
| Q4 25 | 81.4% | 34.1% | ||
| Q3 25 | 80.1% | 36.5% | ||
| Q2 25 | 79.1% | 39.9% | ||
| Q1 25 | 77.3% | 41.9% | ||
| Q4 24 | 78.4% | 38.6% | ||
| Q3 24 | 90.7% | 43.0% | ||
| Q2 24 | 90.7% | 41.8% | ||
| Q1 24 | 90.9% | 40.0% |
| Q4 25 | 4.9% | -13.5% | ||
| Q3 25 | 1.2% | -7.7% | ||
| Q2 25 | -8.6% | -3.3% | ||
| Q1 25 | -5.2% | -1.9% | ||
| Q4 24 | 5.5% | -4.1% | ||
| Q3 24 | -1.6% | -2.3% | ||
| Q2 24 | -5.9% | -3.4% | ||
| Q1 24 | -1.4% | -11.0% |
| Q4 25 | 6.5% | -13.2% | ||
| Q3 25 | 6.4% | -7.6% | ||
| Q2 25 | 0.7% | -3.0% | ||
| Q1 25 | 7.4% | -1.3% | ||
| Q4 24 | 0.1% | -3.4% | ||
| Q3 24 | -10.5% | -1.4% | ||
| Q2 24 | -11.9% | -2.4% | ||
| Q1 24 | 3.2% | -10.3% |
| Q4 25 | $0.06 | — | ||
| Q3 25 | $0.06 | — | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.21 | — | ||
| Q2 24 | $-0.24 | — | ||
| Q1 24 | $0.06 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.6M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.1M | $11.5M |
| Total Assets | $61.0M | $19.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.6M | $5.1M | ||
| Q3 25 | $29.7M | $5.1M | ||
| Q2 25 | $29.8M | $3.9M | ||
| Q1 25 | $21.9M | $7.0M | ||
| Q4 24 | $25.1M | $8.3M | ||
| Q3 24 | $20.7M | $7.9M | ||
| Q2 24 | $17.5M | $7.6M | ||
| Q1 24 | $18.7M | $7.1M |
| Q4 25 | $15.1M | $11.5M | ||
| Q3 25 | $22.7M | $12.8M | ||
| Q2 25 | $23.2M | $13.4M | ||
| Q1 25 | $22.8M | $13.3M | ||
| Q4 24 | $20.7M | $13.2M | ||
| Q3 24 | $20.5M | $13.1M | ||
| Q2 24 | $23.2M | $12.6M | ||
| Q1 24 | $26.2M | $12.7M |
| Q4 25 | $61.0M | $19.2M | ||
| Q3 25 | $69.4M | $18.9M | ||
| Q2 25 | $73.2M | $20.4M | ||
| Q1 25 | $80.1M | $21.5M | ||
| Q4 24 | $83.2M | $19.3M | ||
| Q3 24 | $79.6M | $18.8M | ||
| Q2 24 | $82.4M | $18.0M | ||
| Q1 24 | $85.7M | $17.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $68.4K |
| Free Cash FlowOCF − Capex | $334.7K | — |
| FCF MarginFCF / Revenue | 2.2% | — |
| Capex IntensityCapex / Revenue | 9.9% | — |
| Cash ConversionOCF / Net Profit | 1.86× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8M | $68.4K | ||
| Q3 25 | $1.8M | $1.2M | ||
| Q2 25 | $868.6K | $-2.8M | ||
| Q1 25 | $-3.7M | $-1.3M | ||
| Q4 24 | $9.4M | $339.2K | ||
| Q3 24 | $3.4M | $305.8K | ||
| Q2 24 | $-973.5K | $642.7K | ||
| Q1 24 | $2.8M | $-422.3K |
| Q4 25 | $334.7K | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $363.6K | — | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | $8.2M | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $-1.2M | — | ||
| Q1 24 | $2.4M | — |
| Q4 25 | 2.2% | — | ||
| Q3 25 | 10.9% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | -30.8% | — | ||
| Q4 24 | 55.9% | — | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | -4.1% | — | ||
| Q1 24 | 8.1% | — |
| Q4 25 | 9.9% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 8.1% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | 1.86× | — | ||
| Q3 25 | 2.07× | — | ||
| Q2 25 | 9.30× | — | ||
| Q1 25 | -3.82× | — | ||
| Q4 24 | 532.98× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |